Enduring Material

Dermatology/Rheumatology Collaborative with a Focus on Skin of Color in partnership with PPACMAN and supported by AbbVie
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
 
 
National Psoriasis Foundation

6600 SW 92nd Ave., Suite 300
Portland, OR 97223-7195
General Information
Wednesday, November 10, 2021 - Thursday, December 12, 2024
200 minutes
National Psoriasis Foundation
Virtual Conference Room
Dermatology/Rheumatology Collaborative with a Focus on Skin of Color in partnership with PPACMAN and supported by AbbVie
National Psoriasis Foundation
Objectives
  • Understanding appropriate diagnosis of psoriatic disease in skin of color and underserved from a cross-disciplinary perspective
  • Outlining the safety, efficacy, and role of current and emerging treatments in addressing both skin and joint symptoms for psoriasis and psoriatic arthritis
  • Addressing comorbid conditions in diverse populations and in specific regions of the United States
  • Applying a patient-centric, collaborative care and appropriate shared management model for treatment of psoriatic disease in patients
Presentations and Speakers
Dermatology/Rheumatology Collaborative with a Focus in Skin of Color in partnership with PPACMAN and supported by Abbvie.
  • Seemal R. Desai, MD, FAAD
  • Sheetal Desai, MD - UC Irvine
  • Erin Boh, MD, PhD, FAAD
  • Niti Goel, MD
  • Junko Takeshita, MD, PhD, MSCE, FAAD
  • Paras Karmacharya, MD, MS
  • Tiffany Mayo, MD, MS, FAAD
Available Credits/Points
  • The National Psoriasis Foundation designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The National Psoriasis Foundation designates this enduring material for a maximum of 2 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Dermatology/Rheumatology Collaborative with a Focus on Skin of Color
Disclosure Statements
Speakers:
Erin Boh, MD, PhD, FAAD and Paras Karmacharya, MD, MS have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Seemal R. Desai, MD, FAAD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • AbbVie - Contracted Research
  • Galderma Laboratories, LP - Consulting
  • Cassiopea SpA - Consulting
  • Ortho Dermatologics - Consulting
  • Ortho Dermatologics - Consulting
  • SkinCeuticals LLC - Consulting
  • Dermira - Consulting
  • Foundation for Research & Education of Dermatology - Advisory Committee Member
  • Almirall - Consulting
  • Almirall - Speaking
  • Dermavant - Advisory Committee Member
  • Scientis - Consulting
  • Sente Labs - Consulting
  • Foamix - Consulting
  • Pfizer - Consulting
  • Verrica Pharmaceuticals Inc - Consulting
  • Atacama Therapeutics - Investigator
  • Ferndale Laboratories, Inc. - Consulting
  • Incyte Corporation - Investigator
  • Gore Range Capital - Stockholder
  • Gore Range Capital - Consulting
  • Incyte Corporation - Consulting
  • Dermavant Sciences - Investigator
  • AOBiome, LLC - Investigator
  • Brickell Biotech, Inc - investigator
  • BMS - Consulting
  • UCB - Consulting
  • Galderma Laboratories, LP - Speaking
  • EPI Health - Consulting
Sheetal Desai, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Janssen - Speakers Bureau - Relationship Has Not Ended
Niti Goel, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • UCB - Stock - Relationship Has Not Ended
Tiffany Mayo, MD, MS, FAAD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Lilly - Advisory Committee Member - Relationship Has Not Ended
  • ChemoCentryx - Principal Investigator - Relationship Has Not Ended
  • Janssen - Advisory Committee Member - Relationship Has Not Ended
  • Novartis - Advisory Committee Member - Relationship Has Not Ended
  • Pfizer - Advisory Committee Member - Relationship Has Not Ended
Junko Takeshita, MD, PhD, MSCE, FAAD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Pfizer - Consulting - Relationship Has Not Ended
  • Janssen - Consulting - Relationship Has Not Ended

Accreditation Statement
  • The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
0 %
100 %
1/5/2022
Continue to Enduring Material